Helixmith Co. Ltd (084990) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.013x

Based on the latest financial reports, Helixmith Co. Ltd (084990) has a cash flow conversion efficiency ratio of -0.013x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.87 Billion ≈ $-1.27 Million USD) by net assets (₩140.28 Billion ≈ $95.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 084990 equity to assets ratio to measure how much of total assets are equity-financed.

Helixmith Co. Ltd - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Helixmith Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Helixmith Co. Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Helixmith Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Helixmith Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Zaklad Budowy Maszyn ZREMB-CHOJNICE S.A.
WAR:ZRE
0.014x
Central Petroleum Ltd
AU:CTP
0.120x
Elsoft Research Bhd
KLSE:0090
0.003x
Global Menkul Degerler AS
IS:GLBMD
0.070x
Key Tronic Corporation
NASDAQ:KTCC
-0.039x
WM Technology Inc
NASDAQ:MAPS
0.047x
Koss Corporation
NASDAQ:KOSS
-0.020x
Global SM Tech Limited
KQ:900070
0.009x

Annual Cash Flow Conversion Efficiency for Helixmith Co. Ltd (2010–2025)

The table below shows the annual cash flow conversion efficiency of Helixmith Co. Ltd from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see Helixmith Co. Ltd (084990) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩141.52 Billion
≈ $95.91 Million
₩-6.90 Billion
≈ $-4.67 Million
-0.049x +58.59%
2024-12-31 ₩142.04 Billion
≈ $96.26 Million
₩-16.72 Billion
≈ $-11.33 Million
-0.118x +30.11%
2023-12-31 ₩153.72 Billion
≈ $104.18 Million
₩-25.89 Billion
≈ $-17.54 Million
-0.168x +10.38%
2022-12-31 ₩216.80 Billion
≈ $146.92 Million
₩-40.74 Billion
≈ $-27.61 Million
-0.188x -10.96%
2021-12-31 ₩225.35 Billion
≈ $152.72 Million
₩-38.16 Billion
≈ $-25.86 Million
-0.169x +2.54%
2020-12-31 ₩276.30 Billion
≈ $187.25 Million
₩-48.01 Billion
≈ $-32.54 Million
-0.174x +17.25%
2019-12-31 ₩195.57 Billion
≈ $132.53 Million
₩-41.07 Billion
≈ $-27.83 Million
-0.210x -108.92%
2018-12-31 ₩133.87 Billion
≈ $90.72 Million
₩-13.46 Billion
≈ $-9.12 Million
-0.101x -538.11%
2017-12-31 ₩164.45 Billion
≈ $111.45 Million
₩-2.59 Billion
≈ $-1.76 Million
-0.016x -9.76%
2016-12-31 ₩170.93 Billion
≈ $115.84 Million
₩-2.45 Billion
≈ $-1.66 Million
-0.014x -188.31%
2015-12-31 ₩67.20 Billion
≈ $45.54 Million
₩1.09 Billion
≈ $740.06K
0.016x +9598.28%
2013-12-31 ₩66.97 Billion
≈ $45.38 Million
₩11.22 Million
≈ $7.60K
0.000x +100.30%
2012-12-31 ₩64.45 Billion
≈ $43.68 Million
₩-3.58 Billion
≈ $-2.43 Million
-0.056x -26.50%
2011-12-31 ₩49.78 Billion
≈ $33.74 Million
₩-2.19 Billion
≈ $-1.48 Million
-0.044x +12.11%
2010-12-31 ₩52.72 Billion
≈ $35.73 Million
₩-2.64 Billion
≈ $-1.79 Million
-0.050x --

About Helixmith Co. Ltd

KQ:084990 Korea Food & Tobacco
Market Cap
$35.63 Million
₩52.58 Billion KRW
Market Cap Rank
#23130 Global
#1520 in Korea
Share Price
₩3295.00
Change (1 day)
-5.72%
52-Week Range
₩3010.00 - ₩9470.00
All Time High
₩167270.44
About

Helixmith Co., Ltd, a biotechnology company, discovers and develops biopharmaceuticals for human diseases. The company has a pipeline of novel biologics and herbal therapeutics in the areas of cardiovascular disease, cancer, and immune disorder, with clinical studies ongoing in the United States, Korea, and China. Its flagship product is VM202, a DNA-based drug for cardiovascular and neurological… Read more